End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.89 CNY | +5.22% | -3.02% | -25.92% |
05-28 | China Grants Approval to Zhongsheng Pharma's Eye Drops | MT |
05-15 | Guangdong Zhongsheng Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023 | CI |
Chart calendar Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Upcoming events on Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Past events on Guangdong Zhongsheng Pharmaceutical Co., Ltd.
14/05/2024 07:45 | Annual General Meeting |
22/04/2024 | Q4 2023 Earnings Release |
22/04/2024 | Q1 2024 Earnings Release |
30/10/2023 | Q3 2023 Earnings Release |
21/08/2023 | Q2 2023 Earnings Release |
17/08/2023 07:45 | Extraordinary Shareholders Meeting |
05/05/2023 07:45 | Annual General Meeting |
27/04/2023 | Q1 2023 Earnings Release |
10/04/2023 | Q4 2022 Earnings Release |
16/03/2023 06:45 | Extraordinary Shareholders Meeting |
27/12/2022 06:45 | Extraordinary Shareholders Meeting |
28/10/2022 | Q3 2022 Earnings Release |
08/08/2022 | Interim 2022 Earnings Release |
21/07/2022 07:45 | Extraordinary Shareholders Meeting |
17/05/2022 07:45 | Annual General Meeting |
25/04/2022 | Q1 2022 Earnings Release |
25/04/2022 | FY 2021 Earnings Release |
01/03/2022 06:45 | Extraordinary Shareholders Meeting |
27/10/2021 | Q3 2021 Earnings Release |
27/08/2021 | Interim 2021 Earnings Release |
Past dividends on Guangdong Zhongsheng Pharmaceutical Co., Ltd.
22/05/2024 | Annual 0.2 CNY |
15/05/2023 | Annual 0.2 CNY |
26/05/2022 | Annual 0.2 CNY |
27/05/2021 | Annual 0.2 CNY |
28/05/2020 | Annual 0.2 CNY |
22/05/2019 | Annual 0.2 CNY |
23/05/2018 | Annual 0.18 CNY |
04/06/2017 | Annual 0.18 CNY |
18/05/2016 | Final Payment 0.135 CNY |
31/08/2015 | Interim Payment 0.1 CNY |
Annual results
Fiscal Period | December | 2019 | 2020 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 2 532 2 606 -2.85% | 1 896 2 323 -18.38% | 0,00 | 2 611 2 837 -7.98% | 3 120 |
EBITDA Million CNY | Released Forecast Spread | 479 574 -16.41% | -225 530 -142.54% | 0,00 | 0,00 0,00 - | 0,00 |
EBIT Million CNY | Released Forecast Spread | 381 523 -27.25% | -324 476 -168.17% | 0,00 | 0,00 0,00 - | 0,00 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 379 531 -28.59% | -345 469 -173.6% | 0,00 | 0,00 0,00 - | 0,00 |
Net income Million CNY | Released Forecast Spread | 318 460 -30.95% | -427 401 -206.4% | 322 | 263 350 -24.78% | 401 |
EPS CNY | Released Forecast Spread | 0,39 0,56 -30.36% | -0,53 0,49 -208.16% | 0,40 | 0,32 0,41 -21.95% | 0,47 |
Announcement Date | 26/02/20 | 26/04/21 | 10/04/23 | 22/04/24 | - |
Quarterly results
Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 539 766 -29.6% | 641 788 -18.64% | 758 | 776 | 799 |
EPS CNY | Released Forecast Spread | -0,02 0,06 -133.33% | 0,06 0,17 -64.71% | 0,14 | 0,09 | 0,07 |
Announcement Date | 22/04/24 | 22/04/24 | - | - | - |
Past sector events for Guangdong Zhongsheng Pharmaceutical Co., Ltd.
21/06/2024 16:28 | DEVA HOLDING: Q1 2024 Earnings Release |
13/06/2024 22:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
11/06/2024 06:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
07/06/2024 11:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
07/06/2024 10:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
30/05/2024 13:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
30/05/2024 12:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
30/05/2024 07:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
29/05/2024 13:00 | FDC LIMITED: Q4 2024 Earnings Release |
29/05/2024 10:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002317 Stock
- Calendar Guangdong Zhongsheng Pharmaceutical Co., Ltd.